Yukito Ichinose

Medicine · Health Sciences

49h-index18.1kcitations329works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(180), Lung Cancer Diagnosis and Treatment(116), Lung Cancer Research Studies(91), Pleural and Pulmonary Diseases(25), Colorectal Cancer Treatments and Studies(23)

Publications329 total

Supplementary Figures S1-8 from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Supplemental Materials from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Supplemental Materials from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Supplementary Figures S1-8 from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Data from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Supplementary Tables S1-5 from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Data from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Supplementary Tables S1-5 from Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
2023Open Access
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)
Lung Cancer·2019· 30 citedOpen Access
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
International Journal of Clinical Oncology·2019· 9 citedOpen Access
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Surgery Today·2019· 7 cited
Gefitinib Plus Bevacizumab <i>vs</i>. Gefitinib Alone for <i>EGFR</i> Mutant Non-squamous Non-small Cell Lung Cancer
In Vivo·2019· 28 citedOpen Access
A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L
British Journal of Cancer·2018· 41 citedOpen Access
Rationale and Design of a Randomized Phase 2 Trial of Gefitinib Plus Bevacizumab vs Gefitinib Alone in Patients with Epidermal Growth Factor Receptor Mutant Non-Squamous Non-Small-Cell Lung Cancer: Study Protocol
The Kurume Medical Journal·2018· 2 citedOpen Access
Impact of somatic mutations on recurrence free survival (RFS) and overall survival (OS) for resected non-small cell lung cancer (NSCLC): results from the Japan Molecular Epidemiology for lung cancer study (JME).
Journal of Clinical Oncology·2018
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol
Clinical Lung Cancer·2018· 10 cited
A case of different EGFR mutations in surgically resected synchronous triple lung cancer
Journal of Thoracic Disease·2018· 4 citedOpen Access
Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the <scp><i>EML4‐ALK</i></scp> fusion gene
Thoracic Cancer·2018· 9 citedOpen Access
The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study
Annals of Surgical Oncology·2018· 25 cited
A Case of Pulmonary Epithelioid Hemangioendothelioma with Surgical Resection
2018
page 1 of 17Next →

Frequent Co-authors

Hiroshi Asoh(11), Nagahiro Saijo(9), Masahiro Fukuoka(9), Kazuhiko Nakagawa(9), Nobuyuki Yamamoto(9), Hideki Yokoyama(9), Tokujiro Yano(9), Yuichiro Ohe(7), Harubumi Kato(7), Koji Takeda(7), Ryosuke Tsuchiya(7), Takashi Seto(7), Mitsuo Ohta(6), Masahiko Ando(6), Yutaka Nishiwaki(5), Tomohide Tamura(5), Toyoaki Hida(5), Shinzoh Kudoh(5), Teruaki Koike(5), Gouji Toyokawa(5)